Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP344785.RAKwErwzNrZ0oz19PLuaoMSufXytcasNQIAEdCR6oGXFM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP344785.RAKwErwzNrZ0oz19PLuaoMSufXytcasNQIAEdCR6oGXFM130_assertion type Assertion NP344785.RAKwErwzNrZ0oz19PLuaoMSufXytcasNQIAEdCR6oGXFM130_head.
- NP344785.RAKwErwzNrZ0oz19PLuaoMSufXytcasNQIAEdCR6oGXFM130_assertion wasGeneratedBy ECO_0000203 NP344785.RAKwErwzNrZ0oz19PLuaoMSufXytcasNQIAEdCR6oGXFM130_provenance.
- NP344785.RAKwErwzNrZ0oz19PLuaoMSufXytcasNQIAEdCR6oGXFM130_assertion wasDerivedFrom befree-2016 NP344785.RAKwErwzNrZ0oz19PLuaoMSufXytcasNQIAEdCR6oGXFM130_provenance.
- NP344785.RAKwErwzNrZ0oz19PLuaoMSufXytcasNQIAEdCR6oGXFM130_assertion SIO_000772 11840259 NP344785.RAKwErwzNrZ0oz19PLuaoMSufXytcasNQIAEdCR6oGXFM130_provenance.
- NP344785.RAKwErwzNrZ0oz19PLuaoMSufXytcasNQIAEdCR6oGXFM130_assertion evidence source_evidence_literature NP344785.RAKwErwzNrZ0oz19PLuaoMSufXytcasNQIAEdCR6oGXFM130_provenance.
- NP344785.RAKwErwzNrZ0oz19PLuaoMSufXytcasNQIAEdCR6oGXFM130_assertion description "[Multivariate COX regression analysis adjusted for chemotherapy protocol, de novo vs secondary AML, and de novo vs relapsed AML indicated: (1) At diagnosis, high expression of Bad (P = 0.015) and even more so high Bax and Bad levels (P = 0.018) predicted adverse outcome, regardless of the response to ICT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344785.RAKwErwzNrZ0oz19PLuaoMSufXytcasNQIAEdCR6oGXFM130_provenance.